These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34403652)

  • 1. Systemic Inflammation Induced Changes in Protein Expression of ABC Transporters and Ionotropic Glutamate Receptor Subunit 1 in the Cerebral Cortex of Familial Alzheimer`s Disease Mouse Model.
    Puris E; Auriola S; Korhonen P; Loppi S; Kanninen KM; Malm T; Koistinaho J; Gynther M
    J Pharm Sci; 2021 Dec; 110(12):3953-3962. PubMed ID: 34403652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Expression of Amino Acid Transporters Is Altered in Isolated Cerebral Microvessels of 5xFAD Mouse Model of Alzheimer's Disease.
    Puris E; Saveleva L; de Sousa Maciel I; Kanninen KM; Auriola S; Fricker G
    Mol Neurobiol; 2023 Feb; 60(2):732-748. PubMed ID: 36367657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered protein expression of membrane transporters in isolated cerebral microvessels and brain cortex of a rat Alzheimer's disease model.
    Puris E; Auriola S; Petralla S; Hartman R; Gynther M; de Lange ECM; Fricker G
    Neurobiol Dis; 2022 Jul; 169():105741. PubMed ID: 35472634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic and lipidomic changes triggered by lipopolysaccharide-induced systemic inflammation in transgenic APdE9 mice.
    Puris E; Kouřil Š; Najdekr L; Loppi S; Korhonen P; Kanninen KM; Malm T; Koistinaho J; Friedecký D; Gynther M
    Sci Rep; 2021 Jun; 11(1):13076. PubMed ID: 34158563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Expression and Activity of Brain Cortical cPLA2 Due to Chronic Lipopolysaccharide Administration in Mouse Model of Familial Alzheimer's Disease.
    Gynther M; Estrada ML; Loppi S; Korhonen P; Kanninen KM; Malm T; Koistinaho J; Auriola S; Fricker G; Puris E
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-Induced Alterations in Brain Drug Transporters in Animal Models of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
    Vellonen KS; Ihalainen J; Boucau MC; Gosselet F; Picardat T; Gynther M; Kanninen KM; White AR; Malm T; Koistinaho J; Forsberg MM; Ruponen M
    Pharm Res; 2017 Dec; 34(12):2652-2662. PubMed ID: 28952054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer's Disease and Systemic Inflammation.
    Zhou J; Yu W; Zhang M; Tian X; Li Y; Lü Y
    Neurochem Res; 2019 May; 44(5):1138-1151. PubMed ID: 30756214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
    Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
    J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic, Lipidomic and Proteomic Characterisation of Lipopolysaccharide-induced Inflammation Mouse Model.
    Puris E; Kouřil Š; Najdekr L; Auriola S; Loppi S; Korhonen P; Gómez-Budia M; Fricker G; Kanninen KM; Malm T; Friedecký D; Gynther M
    Neuroscience; 2022 Aug; 496():165-178. PubMed ID: 35636730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling of brain cortex tissues in a Tau transgenic mouse model of Alzheimer's disease.
    Chang SH; Jung IS; Han GY; Kim NH; Kim HJ; Kim CW
    Biochem Biophys Res Commun; 2013 Jan; 430(2):670-5. PubMed ID: 23211594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered Expression of Small Intestinal Drug Transporters and Hepatic Metabolic Enzymes in a Mouse Model of Familial Alzheimer's Disease.
    Pan Y; Omori K; Ali I; Tachikawa M; Terasaki T; Brouwer KLR; Nicolazzo JA
    Mol Pharm; 2018 Sep; 15(9):4073-4083. PubMed ID: 30074800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ABC transporters in the pathogenesis of Alzheimer's disease.
    Abuznait AH; Kaddoumi A
    ACS Chem Neurosci; 2012 Nov; 3(11):820-31. PubMed ID: 23181169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of Bdnf gene deficiency to the memory impairment and brain pathology of APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Rantamäki T; Kemppainen S; Autio H; Stavén S; Koivisto H; Kojima M; Antila H; Miettinen PO; Kärkkäinen E; Karpova N; Vesa L; Lindemann L; Hoener MC; Tanila H; Castrén E
    PLoS One; 2013; 8(7):e68722. PubMed ID: 23844236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model.
    Lv J; Ma S; Zhang X; Zheng L; Ma Y; Zhao X; Lai W; Shen H; Wang Q; Ji J
    J Proteomics; 2014 Oct; 110():45-58. PubMed ID: 25108202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlapping functions of ABC transporters in topotecan disposition as determined in gene knockout mouse models.
    Tiwari AK; Zhang R; Gallo JM
    Mol Cancer Ther; 2013 Jul; 12(7):1343-55. PubMed ID: 23635651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-specific changes in protein expression of membrane transporters in the brain cortex of 5xFAD mouse model of Alzheimer's disease.
    Puris E; Saveleva L; Auriola S; Gynther M; Kanninen KM; Fricker G
    Front Pharmacol; 2024; 15():1365051. PubMed ID: 38572427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.
    Rangaraju S; Dammer EB; Raza SA; Gao T; Xiao H; Betarbet R; Duong DM; Webster JA; Hales CM; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2018 Jun; 13(1):34. PubMed ID: 29954413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease.
    Sui X; Ren X; Huang P; Li S; Ma Q; Ying M; Ni J; Liu J; Yang X
    J Alzheimers Dis; 2014; 40(3):575-86. PubMed ID: 24496070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.